Wyeth Pharmaceuticals - search results

অস্ট্রেলিয়া - ইংরেজি - Department of Health (Therapeutic Goods Administration)

estraderm mx

novartis pharmaceuticals australia pty ltd - oestradiol; oestradiol hemihydrate -

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

highlights of prescribing information

pd-rx pharmaceuticals, inc. - desvenlafaxine succinate (unii: zb22enf0xr) (desvenlafaxine - unii:ng99554anw) - desvenlafaxine 50 mg - pristiq is indicated for the treatment of adults with major depressive disorder (mdd) [see clinical studies (14)] . - hypersensitivity to desvenlafaxine succinate, venlafaxine hydrochloride or to any excipients in the pristiq formulation. angioedema has been reported in patients treated with pristiq [see adverse reactions (6.1)] . - the use of maois intended to treat psychiatric disorders with pristiq or within 7 days of stopping treatment with pristiq is contraindicated because of an increased risk of serotonin syndrome. the use of pristiq within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated [see dosage and administration (2.7) and warnings and precautions (5.2)]. - starting pristiq in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased